(Velo-201 DigiFab) A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of DigiFab? in Antepartum Subjects with Severe Preeclampsia

Project: Other project

StatusActive
Effective start/end date2/23/172/22/21

Funding

  • Velo Bio LLC: $25,276.39